TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013
TCL Archive Studies Are Demonstrating Effectiveness of Drug Combinations As Adjuvant Therapy; NCI Will Support New Clinical Trials April 5, 1974
TCL Archive Ohio State Becomes 18th Comprehensive Center; UCLA Needs Only To Overcome “Minor” Problems April 16, 1976
TCL Archive NCI Eases Some Cooperative Group Concern; DeVita Considers Other CCOP- Research Base Funding Option April 2, 1982
